15.11.2019 - Kulakov Vladimir

European shares recorded a weak ended session as warnings from German carmaker Daimler and frail economic data from major economies contributed tension to a global slowdown concern.

The pan-European STOXX 600 index inched lower with 0.3% with most sectors contributing to the inactivity and automakers .SXAP leading the decline with 1.4%.

Daimler (Daign.DE) plummeted with 3% as it was recorded to be the biggest setback on Germany’s blue-chip index .GDAXI. This followed after the German carmaker stated that stronger emissions guidelines would hit gains in 2020 and 2021. In line with this, the firm decided to cut staff costs at its Mercedez-Benz business to acquire more than 1 Billion Euros ($1.1 billion) in savings.

“It’s been well known that the shift to electric will be a difficult one and there is a no real timeline on when the companies will start seeing a turnaround,” said Ken Odeluga, market analyst at City Index in London.

Weak global auto shares affected German carmakers with economic underperformance in China as new emissions-testing guidelines worsen the sector’s current state.

Germany, Europe’s biggest economy, deviated from recession in third quarter while growth indicators from Japan and China fell short, heavily dragging global economy to a slowdown.

The overall economic slowdown hindered European shares from continuing its four-year high record boosted by optimism that the ‘phase one’ of Sino-US trade pact will get signed and better-than-expected gains.

“The initial optimism that we were seeing for the first phase to be completed seems to be a bit overoptimistic now as there seem to be some stumbling blocks,” said Michael Baker, analyst at ETX Capital.

Defensive plays which include .SX6P, healthcare .SXDP, and telecoms .SXDP, which investors took benefit earlier this week started to falter as all hit a record between 0.3% and 1%.

London’s FTSE 100 .FTSE was down with 0.8% as it tallied a 6% setback in private equity firm 3i.

STOXX 600’S top performer was Qiagen, a genetic testing company which soared up to 14% following Bloomberg’s report that Thermo Fisher Scientific sealed a deal with the company.

Risk disclaimer "PROMETHEUS LTD – Trust Company Complex, Ajeltake Road, Ajeltake Island, Majuro, Republic of the Marshall Islands MH96960 is a financial services institution outside the European Union Area, which is subject to the supervision of the IFMRRC Certificate 0395 AA V0155 Trading in Forex/ CFDs and Other Derivatives is highly speculative and carries a high level of risk. It is possible to lose all your capital. 70% of trading deals can be unprofitable. These products may not be suitable for everyone and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. This Website may contain information in particular regarding financial services and products that could be regarded b a E.U. supervisory authority as an offer of financial services targeted in Europe. ESMA intervention measures do not apply to customers of PROMETHEUS LTD and it is your responsibility to choose a company which is most suitable for your trading needs. By clicking continue you confirm that you have read, understood and agree to the risk disclosures, terms of service, cash policies, privacy policies and this notice and that you are visiting this website on your own initiative, without any encouragement whatsoever from or PROMETHEUS LTD." Cookies notification: We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we assume that you are happy with it. Read more. Continue

Help with deposit?